Back
DocuSign, Inc. Vs. Nektar Therapeutics Industry Stock Comparison
Buy
71
DOCU
DocuSign, Inc.
Last Price:
$71.11
Seasonality Move:
-1.87%
Sell
33
NKTR
Nektar Therapeutics
Last Price:
$54.70
Seasonality Move:
11.58%
Buy
71
DocuSign, Inc. (DOCU)
is a Buy
Is DocuSign, Inc. a Buy, Sell or Hold?
-
The current DocuSign, Inc. [DOCU] share price is $70.23. The Score for DOCU is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
DOCU is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $51.12. The Score for NKTR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DOCU Stock Price Chart
What is DocuSign, Inc.'s stock price today?
-
The DocuSign, Inc. share price today is $70.23Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DOCU is experiencing slight buying pressure.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $51.12The current trend is relatively stagnant and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.
DOCU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 54.05 | Buy |
| Chaikin Money Flow: | 1269259 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (65.9 - 69.94) | Buy |
| Bollinger Bands (100): | (67.45 - 78.39) | Sell |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.55 | Sell |
| Relative Strength Index (14 RSI): | 39.75 | Sell |
| Chaikin Money Flow: | -893008 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.73 - 61.07) | Sell |
| Bollinger Bands (100): | (32.3 - 62.42) | Buy |
DOCU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.84 | Buy |
| 20-day SMA: | 67.53 | Buy |
| 50-day SMA: | 69.14 | Buy |
| 200-day SMA: | 76.92 | Sell |
| 8-day EMA: | 68.75 | Buy |
| 20-day EMA: | 68.52 | Buy |
| 50-day EMA: | 69.99 | Buy |
| 200-day EMA: | 74.4 | Sell |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.44 | Sell |
| 20-day SMA: | 58.08 | Sell |
| 50-day SMA: | 58.52 | Sell |
| 200-day SMA: | 30.43 | Buy |
| 8-day EMA: | 56.58 | Sell |
| 20-day EMA: | 57.71 | Sell |
| 50-day EMA: | 55.82 | Sell |
| 200-day EMA: | 37.69 | Buy |
DocuSign, Inc. Earnings Growth & DOCU Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.66 per share, and an increase next year of $0.24 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.
DocuSign, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||